Share of Clicks for top 10 US Pharma & Biotech Infectious Diseases brands
Here are the Top 10 competitors in the industry by Share of Clicks for the last month.
| Domain | Share of clicks |
|---|---|
| paxlovid.com | 23.48 |
| mavyret.com | 18.01 |
| uqora.com | 7.16 |
| mayoclinic.org | 5.19 |
| epclusa.com | 4.26 |
| admired.com | 3.46 |
| dndi.org | 3.3 |
| cabenuva.com | 3.18 |
| talk-prep.com | 3.15 |
| liverfoundation.org | 2.52 |
| others | 26.29 |
- paxlovid.com - 23.48%
- mavyret.com - 18.01%
- uqora.com - 7.16%
- mayoclinic.org - 5.19%
- epclusa.com - 4.26%
- admired.com - 3.46%
- dndi.org - 3.3%
- cabenuva.com - 3.18%
- talk-prep.com - 3.15%
- liverfoundation.org - 2.52%
- others - 26.29%
Copyright © Adthena. All rights reserved.
In the PPC landscape, paxlovid.com leads with 23.48% click share, closely followed by mavyret.com at 18.01%. Others collectively hold 26.29%, showcasing diverse competition.
Share of Spend for the top 10 US Pharma & Biotech Infectious Diseases brands
Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.
| Date | cabenuva.com | mayoclinic.org | talk-prep.com | dndi.org | dovato.com | uqora.com | epclusa.com | paxlovid.com | mavyret.com | liverfoundation.org |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025/12/01 | 1.74% | 0.14% | 2.15% | 0.16% | 0.33% | 1.58% | 11.19% | 21.77% | 31.5% | 3.57% |
| 2025/12/02 | 7.74% | 0.53% | 3.28% | 0.01% | 12.79% | 5.05% | 2.15% | 24.93% | 16.37% | 0.04% |
| 2025/12/03 | 1.43% | 0.02% | 4.24% | 5.16% | 1.59% | 4.97% | 9.43% | 3.52% | 24.11% | 5.23% |
| 2025/12/04 | 9.97% | 0.4% | 4.06% | 1.81% | 2.4% | 6.42% | 6.84% | 0.29% | 33.69% | 3.53% |
| 2025/12/05 | 3.74% | 11.48% | 3.64% | 0.04% | 1.82% | 1.3% | 10.15% | 5.54% | 22.02% | 5.78% |
| 2025/12/06 | 3.9% | 17.83% | 3.23% | 3.33% | 3.59% | 0.86% | 9.05% | 4.43% | 16.12% | 6.99% |
| 2025/12/07 | 12.22% | 3.92% | 3.71% | 1.62% | 5.78% | 2.57% | 3.27% | 0.35% | 27.78% | 8.72% |
| 2025/12/08 | 5.8% | 5.82% | 3.73% | 0.18% | 4.5% | 6.02% | 9.03% | 3.74% | 15.93% | 1.96% |
| 2025/12/09 | 4.22% | 3.76% | 3.23% | 1.52% | 7.45% | 3.4% | 10.42% | 7.91% | 18.38% | 5.59% |
| 2025/12/10 | 5.4% | 7.58% | 3.63% | 3.62% | 4.07% | 1.62% | 7.99% | 8.62% | 21.62% | 5.89% |
| 2025/12/11 | 8.38% | 1.86% | 3.29% | 1.2% | 5.39% | 0% | 9.42% | 9.96% | 22.08% | 7.72% |
| 2025/12/12 | 7.46% | 1.68% | 4.55% | 1.98% | 8.11% | 0.86% | 4.85% | 6.02% | 23.82% | 5.38% |
| 2025/12/13 | 5.87% | 5.49% | 3.19% | 1.42% | 1.61% | 6.19% | 1.93% | 10.98% | 20.42% | 8.23% |
| 2025/12/14 | 2.75% | 4.96% | 2.51% | 2.86% | 14.6% | 4.31% | 3.38% | 7.02% | 20.65% | 6.18% |
| 2025/12/15 | 1.99% | 7.58% | 3.79% | 1.33% | 4.37% | 6.01% | 4.83% | 9.93% | 24.22% | 6.12% |
| 2025/12/16 | 7.75% | 3.01% | 3.6% | 2.24% | 9.98% | 2.07% | 2.72% | 9.83% | 21.29% | 7.92% |
| 2025/12/17 | 4.88% | 1.66% | 5.39% | 3.32% | 3.94% | 2.2% | 5.9% | 4.43% | 31.24% | 2.09% |
| 2025/12/18 | 4.39% | 5.56% | 3.86% | 8.9% | 5.46% | 2.81% | 1.52% | 5.09% | 30.19% | 0.04% |
| 2025/12/19 | 2.6% | 2.13% | 3.9% | 7.85% | 8.67% | 5.78% | 6.18% | 8.7% | 21.46% | 0.04% |
| 2025/12/20 | 2.73% | 4.75% | 3.39% | 3.84% | 6.77% | 4.12% | 3.37% | 10.14% | 23.17% | 0.04% |
| 2025/12/21 | 4.63% | 7.28% | 2.89% | 6.88% | 8.39% | 4% | 7.69% | 4.98% | 20.26% | 0.03% |
| 2025/12/22 | 4.94% | 6.54% | 3.88% | 5.12% | 9.93% | 1.38% | 8.83% | 6.34% | 24.69% | 0.02% |
| 2025/12/23 | 10.41% | 3.09% | 3.6% | 5.19% | 8.93% | 4.94% | 4.45% | 3.95% | 23.56% | 0.02% |
| 2025/12/24 | 7.28% | 1.49% | 5.49% | 5.13% | 8.81% | 0% | 4.76% | 5.81% | 19.94% | 0% |
| 2025/12/25 | 9.6% | 3.12% | 5.52% | 4.92% | 6.9% | 0% | 3.83% | 4.54% | 21.45% | 0% |
| 2025/12/26 | 11.06% | 13.97% | 4.16% | 2.79% | 2.1% | 2.41% | 6.22% | 3.78% | 20.27% | 0% |
| 2025/12/27 | 5.7% | 3.07% | 4.31% | 4.42% | 5.02% | 3.32% | 5.23% | 6.34% | 32.28% | 0% |
| 2025/12/28 | 3.62% | 5.47% | 4.81% | 6.5% | 4.32% | 1.94% | 5.48% | 4.28% | 35.83% | 0% |
| 2025/12/29 | 12.07% | 0.53% | 4.88% | 5.16% | 3.06% | 2.17% | 4.53% | 2.61% | 29.23% | 0% |
| 2025/12/30 | 7.14% | 4.72% | 4.69% | 5.64% | 6.98% | 4.29% | 5.87% | 3.97% | 27.33% | 0% |
| 2025/12/31 | 11.62% | 9.36% | 7.36% | 7.2% | 6.43% | 3.98% | 3.8% | 3.22% | 2.22% | 0% |
- cabenuva.com
- mayoclinic.org
- talk-prep.com
- dndi.org
- dovato.com
- uqora.com
- epclusa.com
- paxlovid.com
- mavyret.com
- liverfoundation.org
Copyright © Adthena. All rights reserved.
In December 2025, mavyret.com dominated PPC spend, peaking at 35.83 on the 28th. cabenuva.com and paxlovid.com showed fluctuating trends, while liverfoundation.org’s activity dwindled, ending at 0.0.
Competitor Count for US Pharma & Biotech Infectious Diseases
Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.
| Date | Competitor Count |
|---|---|
| 2025/12/01 | 91 |
| 2025/12/02 | 87 |
| 2025/12/03 | 86 |
| 2025/12/04 | 91 |
| 2025/12/05 | 95 |
| 2025/12/06 | 88 |
| 2025/12/07 | 89 |
| 2025/12/08 | 88 |
| 2025/12/09 | 89 |
| 2025/12/10 | 89 |
| 2025/12/11 | 88 |
| 2025/12/12 | 92 |
| 2025/12/13 | 87 |
| 2025/12/14 | 89 |
| 2025/12/15 | 87 |
| 2025/12/16 | 94 |
| 2025/12/17 | 94 |
| 2025/12/18 | 88 |
| 2025/12/19 | 90 |
| 2025/12/20 | 90 |
| 2025/12/21 | 92 |
| 2025/12/22 | 91 |
| 2025/12/23 | 91 |
| 2025/12/24 | 93 |
| 2025/12/25 | 89 |
| 2025/12/26 | 87 |
| 2025/12/27 | 90 |
| 2025/12/28 | 88 |
| 2025/12/29 | 92 |
| 2025/12/30 | 89 |
| 2025/12/31 | 89 |
Copyright © Adthena. All rights reserved.
Advertisers fluctuated throughout December, peaking at 95 on the 5th. The month concluded with a stable count of 89.
